WO2022223515 - COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION
National phase entry:
Publication Number
WO/2022/223515
Publication Date
27.10.2022
International Application No.
PCT/EP2022/060238
International Filing Date
19.04.2022
Title **
[English]
COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION
[French]
COMPOSITIONS ET PROCÉDÉS POUR INHIBER L'EXPRESSION DE L'ÉLÉMENT 3 DU GROUPE H DE LA SOUS-FAMILLE 1 DE RÉCEPTEUR NUCLÉAIRE (NR1H3)
Applicants **
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
DICERNA PHARMACEUTICALS, INC.
75 Hayden Avenue
Lexington, Massachusetts 02421, US
Inventors
SAXENA, Utsav
75 Hayden Avenue
Lexington, MA02421, US
DUDEK, Henryk
75 Hayden Avenue
Lexington, MA02421, US
PURSELL, Natalie, Wayne
75 Hayden Avenue
Lexington, MA02421, US
SPIEGELMAN, Nicole, Alexis
75 Hayden Avenue
Lexington, MA02421, US
LATTA, Markus, Robert
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
ANDERSEN, Birgitte
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
Priority Data
63/176,814
19.04.2021
US
21213711.1
10.12.2021
EP
21186366.7
19.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3652 | |
| EPO | Filing, Examination | 10896 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 640 | |
| USA | Filing, Examination | 8560 |
Total: 24337 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
expression.[French]
.